In this study, we investigated the expression of three biomarkers (GRPR, PSMA, and NTR1) in different stages of precancerous lesions and prostate cancer patients (PIN, PCa, and lymph node metastasis). This evidence concerns the gene FOLH1 and prostate cancer.